For those into patents as well as #Biosimilars: @US_FDA Developing Guidance For First Interchangeable Exclusivity https://t.co/dP3swLuZcJ
For those into patents as well as #Biosimilars: @US_FDA Developing Guidance For First Interchangeable Exclusivity https://t.co/dP3swLuZcJ